Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pooja Shah

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Environmental Research and Public Health|June 10, 2023
Violence across the Life Course and Implications for Intervention Design: Findings from the Maisha Fiti Study with Female Sex Workers in Nairobi, KenyaTara S Beattie, Rhoda Kabuti, Alicja Beksinska, et al.
AIDS and Behavior|August 13, 2024
Factors Associated with Usage of Oral-PrEP among Female Sex Workers in Nairobi, Kenya, Assessed by Self-Report and a Point-of-Care Urine Tenofovir ImmunoassayPooja Shah, Matthew Spinelli, Erastus Irungu, et al.
Gynecologic Oncology|December 13, 2022
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 studyMaria M Rubinstein, Eric Rios Doria, Jason Konner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial CancerAngela K Green, Qin Zhou, Alexia Iasonos, et al.
International Journal of Environmental Research and Public Health|June 10, 2023
Conducting Violence and Mental Health Research with Female Sex Workers during the COVID-19 Pandemic: Ethical Considerations, Challenges, and Lessons Learned from the Maisha Fiti Study in Nairobi, KenyaMary Kung'u, Rhoda Kabuti, Hellen Babu, et al.
The Journal of Biological Chemistry|April 12, 2026
Meeting Report on FASEB Protein Arginine Methylation: Mechanism to TherapeuticsDavid Shechter, Rong Huang, Pooja Shah, et al.
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
Circulation Research|December 7, 2016
Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling LoopHema Viswambharan, Nadira Y Yuldasheva, Anshuman Sengupta, et al.
Mabs|October 8, 2025
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody designPeng Zhao, John Schardt, Chi-I Chiang, et al.
Mabs|August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine releaseJohn S Schardt, Even Walseng, Kim Le, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Environmental Research and Public Health|June 10, 2023
Violence across the Life Course and Implications for Intervention Design: Findings from the Maisha Fiti Study with Female Sex Workers in Nairobi, KenyaTara S Beattie, Rhoda Kabuti, Alicja Beksinska, et al.
AIDS and Behavior|August 13, 2024
Factors Associated with Usage of Oral-PrEP among Female Sex Workers in Nairobi, Kenya, Assessed by Self-Report and a Point-of-Care Urine Tenofovir ImmunoassayPooja Shah, Matthew Spinelli, Erastus Irungu, et al.
Gynecologic Oncology|December 13, 2022
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 studyMaria M Rubinstein, Eric Rios Doria, Jason Konner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial CancerAngela K Green, Qin Zhou, Alexia Iasonos, et al.
International Journal of Environmental Research and Public Health|June 10, 2023
Conducting Violence and Mental Health Research with Female Sex Workers during the COVID-19 Pandemic: Ethical Considerations, Challenges, and Lessons Learned from the Maisha Fiti Study in Nairobi, KenyaMary Kung'u, Rhoda Kabuti, Hellen Babu, et al.
The Journal of Biological Chemistry|April 12, 2026
Meeting Report on FASEB Protein Arginine Methylation: Mechanism to TherapeuticsDavid Shechter, Rong Huang, Pooja Shah, et al.
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
Circulation Research|December 7, 2016
Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling LoopHema Viswambharan, Nadira Y Yuldasheva, Anshuman Sengupta, et al.
Mabs|October 8, 2025
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody designPeng Zhao, John Schardt, Chi-I Chiang, et al.
Mabs|August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine releaseJohn S Schardt, Even Walseng, Kim Le, et al.
Pageof 14